Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are the major downstream effectors of the Hippo pathway, which regulates tissue homeostasis, organ size, regeneration and tumorigenesis. In this Progress article, we summarize the current understanding of the biological functions of YAP and TAZ, and how the regulation of these two proteins can be disrupted in cancer. We also highlight recent findings on their expanding role in cancer progression and describe the potential of these targets for therapeutic intervention
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
Yes‐associated protein (YAP) has emerged as a key component in cancer signaling and is considered a ...
The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) ar...
Dysregulated Hippo pathway signaling promotes the onset of aggressive cancers through the induced nu...
Our understanding of the function of the transcriptional regulators YAP and TAZ (YAP/TAZ) in cancer ...
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both...
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both...
The Hippo signaling pathway is a highly-conserved developmental pathway that plays an essential role...
Abstract Yes-associated protein (YAP) and its paralog WW domain containing transcription regulator 1...
Lung cancer is the leading cause of cancer death in the world and there is no current treatment able...
Yes-associated protein (YAP) has emerged as a key component in cancer signaling and is considered a ...
The Hippo signalling pathway is an emerging growth control and tumour suppressor pathway that regula...
The Hippo signalling pathway is an emerging growth control and tumour suppressor pathway that regula...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
Yes‐associated protein (YAP) has emerged as a key component in cancer signaling and is considered a ...
The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) ar...
Dysregulated Hippo pathway signaling promotes the onset of aggressive cancers through the induced nu...
Our understanding of the function of the transcriptional regulators YAP and TAZ (YAP/TAZ) in cancer ...
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both...
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both...
The Hippo signaling pathway is a highly-conserved developmental pathway that plays an essential role...
Abstract Yes-associated protein (YAP) and its paralog WW domain containing transcription regulator 1...
Lung cancer is the leading cause of cancer death in the world and there is no current treatment able...
Yes-associated protein (YAP) has emerged as a key component in cancer signaling and is considered a ...
The Hippo signalling pathway is an emerging growth control and tumour suppressor pathway that regula...
The Hippo signalling pathway is an emerging growth control and tumour suppressor pathway that regula...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
The Hippo pathway is an important organ size control signaling network and the major regulatory mech...
Yes‐associated protein (YAP) has emerged as a key component in cancer signaling and is considered a ...